Microbiome mediation of infections in the cancer setting.

Abstract:

:Infections encountered in the cancer setting may arise from intensive cancer treatments or may result from the cancer itself, leading to risk of infections through immune compromise, disruption of anatomic barriers, and exposure to nosocomial (hospital-acquired) pathogens. Consequently, cancer-related infections are unique and epidemiologically distinct from those in other patient populations and may be particularly challenging for clinicians to treat. There is increasing evidence that the microbiome is a crucial factor in the cancer patient's risk for infectious complications. Frequently encountered pathogens with observed ties to the microbiome include vancomycin-resistant Enterococcus, Enterobacteriaceae, and Clostridium difficile; these organisms can exist in the human body without disease under normal circumstances, but all can arise as infections when the microbiome is disrupted. In the cancer patient, such disruptions may result from interventions such as chemotherapy, broad-spectrum antibiotics, or anatomic alteration through surgery. In this review, we discuss evidence of the significant role of the microbiome in cancer-related infections; how a better understanding of the role of the microbiome can facilitate our understanding of these complications; and how this knowledge might be exploited to improve outcomes in cancer patients and reduce risk of infection.

journal_name

Genome Med

journal_title

Genome medicine

authors

Taur Y,Pamer EG

doi

10.1186/s13073-016-0306-z

subject

Has Abstract

pub_date

2016-04-18 00:00:00

pages

40

issue

1

issn

1756-994X

pii

10.1186/s13073-016-0306-z

journal_volume

8

pub_type

杂志文章,评审
  • Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma.

    abstract:BACKGROUND:Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine carcinoma of the skin caused by either the integration of Merkel cell polyomavirus (MCPyV) and expression of viral T antigens or by ultraviolet-induced damage to the tumor genome from excessive sunlight exposure. An increasing number of deep s...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00727-4

    authors: Starrett GJ,Thakuria M,Chen T,Marcelus C,Cheng J,Nomburg J,Thorner AR,Slevin MK,Powers W,Burns RT,Perry C,Piris A,Kuo FC,Rabinowits G,Giobbie-Hurder A,MacConaill LE,DeCaprio JA

    更新日期:2020-03-18 00:00:00

  • Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine.

    abstract::Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road for the use of prec...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00757-y

    authors: Benech N,Sokol H

    更新日期:2020-06-30 00:00:00

  • PPAR action in insulin resistance unraveled by metabolomics: potential clinical implications.

    abstract::Metabolomic analysis will provide the next large set of clues to further our understanding of human health and disease. A recent study has elucidated the significant differences in the metabolomes of adipocytes, serum and an adipocyte cell line after activation of two nuclear receptors, peroxisome proliferator activat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm270

    authors: Patterson AD,Peters JM

    更新日期:2011-08-23 00:00:00

  • Host genetic variation and its microbiome interactions within the Human Microbiome Project.

    abstract:BACKGROUND:Despite the increasing recognition that microbial communities within the human body are linked to health, we have an incomplete understanding of the environmental and molecular interactions that shape the composition of these communities. Although host genetic factors play a role in these interactions, these...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0515-8

    authors: Kolde R,Franzosa EA,Rahnavard G,Hall AB,Vlamakis H,Stevens C,Daly MJ,Xavier RJ,Huttenhower C

    更新日期:2018-01-29 00:00:00

  • Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned.

    abstract::Candidate gene association studies, linkage studies and genome-wide association studies have highlighted the role of genetic factors in the development of ischemic stroke. This research started over a decade ago, and can be separated into three major periods of research. In the first wave classic susceptibility marker...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm185

    authors: Maasz A,Melegh B

    更新日期:2010-09-13 00:00:00

  • Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.

    abstract::Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation fr...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm180

    authors: Morris MR,Maher ER

    更新日期:2010-09-03 00:00:00

  • Stem cell banking: between traceability and identifiability.

    abstract::Stem cell banks are increasingly seen as an essential resource of biological materials for both basic and translational research. Stem cell banks support transnational access to quality-controlled and ethically sourced stem cell lines from different origins and of varying grades. According to the Organisation for Econ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm194

    authors: Knoppers BM,Isasi R

    更新日期:2010-10-05 00:00:00

  • Predictive, preventive, personalized and participatory medicine: back to the future.

    abstract::The pioneering work of Jean Dausset on the HLA system established several principles that were later reflected in the Human Genome Project and contributed to the foundations of predictive, preventive, personalized and participatory (P4) medicine. To effectively develop systems medicine, we should take advantage of the...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm178

    authors: Auffray C,Charron D,Hood L

    更新日期:2010-08-26 00:00:00

  • Creating a data resource: what will it take to build a medical information commons?

    abstract::National and international public-private partnerships, consortia, and government initiatives are underway to collect and share genomic, personal, and healthcare data on a massive scale. Ideally, these efforts will contribute to the creation of a medical information commons (MIC), a comprehensive data resource that is...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0476-3

    authors: Deverka PA,Majumder MA,Villanueva AG,Anderson M,Bakker AC,Bardill J,Boerwinkle E,Bubela T,Evans BJ,Garrison NA,Gibbs RA,Gentleman R,Glazer D,Goldstein MM,Greely H,Harris C,Knoppers BM,Koenig BA,Kohane IS,La Rosa S,

    更新日期:2017-09-22 00:00:00

  • Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy.

    abstract:BACKGROUND:Preterm birth confers a high risk of adverse long term health outcomes for survivors, yet the underlying molecular mechanisms are unclear. We hypothesized that effects of preterm birth can be mediated through measurable epigenomic changes throughout development. We therefore used a longitudinal birth cohort ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm500

    authors: Cruickshank MN,Oshlack A,Theda C,Davis PG,Martino D,Sheehan P,Dai Y,Saffery R,Doyle LW,Craig JM

    更新日期:2013-10-18 00:00:00

  • Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

    abstract:BACKGROUND:Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS:A phase II rando...

    journal_title:Genome medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s13073-018-0601-y

    authors: Höglander EK,Nord S,Wedge DC,Lingjærde OC,Silwal-Pandit L,Gythfeldt HV,Vollan HKM,Fleischer T,Krohn M,Schlitchting E,Borgen E,Garred Ø,Holmen MM,Wist E,Naume B,Van Loo P,Børresen-Dale AL,Engebraaten O,Kristensen V

    更新日期:2018-11-29 00:00:00

  • Activation of an endogenous retrovirus-associated long non-coding RNA in human adenocarcinoma.

    abstract:BACKGROUND:Long non-coding RNAs (lncRNAs) are emerging as molecules that significantly impact many cellular processes and have been associated with almost every human cancer. Compared to protein-coding genes, lncRNA genes are often associated with transposable elements, particularly with endogenous retroviral elements ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0142-6

    authors: Gibb EA,Warren RL,Wilson GW,Brown SD,Robertson GA,Morin GB,Holt RA

    更新日期:2015-03-05 00:00:00

  • CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling.

    abstract::CRISPR/Cas9 has revolutionized cancer mouse models. Although loss-of-function genetics by CRISPR/Cas9 is well-established, generating gain-of-function alleles in somatic cancer models is still challenging because of the low efficiency of gene knock-in. Here we developed CRISPR-based Somatic Oncogene kNock-In for Cance...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0627-9

    authors: Mou H,Ozata DM,Smith JL,Sheel A,Kwan SY,Hough S,Kucukural A,Kennedy Z,Cao Y,Xue W

    更新日期:2019-04-16 00:00:00

  • Clinical laboratory test-wide association scan of polygenic scores identifies biomarkers of complex disease.

    abstract:BACKGROUND:Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between genetic ri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00820-8

    authors: Dennis JK,Sealock JM,Straub P,Lee YH,Hucks D,Actkins K,Faucon A,Feng YA,Ge T,Goleva SB,Niarchou M,Singh K,Morley T,Smoller JW,Ruderfer DM,Mosley JD,Chen G,Davis LK

    更新日期:2021-01-13 00:00:00

  • Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.

    abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm385

    authors: Starmans MH,Pintilie M,John T,Der SD,Shepherd FA,Jurisica I,Lambin P,Tsao MS,Boutros PC

    更新日期:2012-11-12 00:00:00

  • Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression.

    abstract:BACKGROUND:Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) are characterised by abnormal epigenetic repression and differentiation of bone marrow haematopoietic stem cells (HSCs). Drugs that reverse epigenetic repression, such as 5-azacytidine (5-AZA), induce haematological improvement in half of trea...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0707-x

    authors: Kazachenka A,Young GR,Attig J,Kordella C,Lamprianidou E,Zoulia E,Vrachiolias G,Papoutselis M,Bernard E,Papaemmanuil E,Kotsianidis I,Kassiotis G

    更新日期:2019-12-23 00:00:00

  • Optimizing the treatment of BRAF mutant melanoma.

    abstract::Selective inhibitors of the kinases BRAF and MEK for the treatment of patients with otherwise refractory BRAF mutant melanoma have demonstrated impressive efficacy, and combination treatment with these agents may prove to be even more effective. However, these drugs are not curative, mainly because of the relatively r...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm547

    authors: Settleman J

    更新日期:2014-04-28 00:00:00

  • Defining functional signatures of dysbiosis in periodontitis progression.

    abstract::Periodontitis is a common inflammatory disease that leads to tooth loss and has been linked to cardiovascular disease and diabetes mellitus. The periodontal microbiome is highly diverse, and metatranscriptomic studies have indicated that the genes that are expressed by the microbiota are more relevant than the microbi...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0165-z

    authors: Wang GP

    更新日期:2015-04-27 00:00:00

  • Open science versus commercialization: a modern research conflict?

    abstract:BACKGROUND:Efforts to improve research outcomes have resulted in genomic researchers being confronted with complex and seemingly contradictory instructions about how to perform their tasks. Over the past decade, there has been increasing pressure on university researchers to commercialize their work. Concurrently, they...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm316

    authors: Caulfield T,Harmon SH,Joly Y

    更新日期:2012-02-27 00:00:00

  • Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci.

    abstract:BACKGROUND:Systemic sclerosis (SSc) is a genetically complex autoimmune disease mediated by the interplay between genetic and epigenetic factors in a multitude of immune cells, with CD4+ T lymphocytes as one of the principle drivers of pathogenesis. METHODS:DNA samples exacted from CD4+ T cells of 48 SSc patients and ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00779-6

    authors: Li T,Ortiz-Fernández L,Andrés-León E,Ciudad L,Javierre BM,López-Isac E,Guillén-Del-Castillo A,Simeón-Aznar CP,Ballestar E,Martin J

    更新日期:2020-09-25 00:00:00

  • Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases.

    abstract::The number of metabolites identified in human cerebrospinal fluid (CSF) has steadily increased over the past 5 years, and in this issue of Genome Medicine David Wishart and colleagues provide a comprehensive update that brings the number of metabolites listed in the CSF metabolome database to 476 compounds. There is n...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm338

    authors: Schwarz E,Torrey EF,Guest PC,Bahn S

    更新日期:2012-04-30 00:00:00

  • Sharing knowledge: a new frontier for public-private partnerships in medicine.

    abstract::To help overcome the bottlenecks that limit the development of diagnostic and therapeutic products, academic and industrial researchers, patient organizations and charities, and regulatory and funding institutions should redefine the basis for sharing the knowledge collected in large-scale clinical and experimental st...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm29

    authors: Auffray C

    更新日期:2009-03-04 00:00:00

  • De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome.

    abstract:BACKGROUND:Molecular diagnostics can resolve locus heterogeneity underlying clinical phenotypes that may otherwise be co-assigned as a specific syndrome based on shared clinical features, and can associate phenotypically diverse diseases to a single locus through allelic affinity. Here we describe an apparently novel s...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm415

    authors: Bainbridge MN,Hu H,Muzny DM,Musante L,Lupski JR,Graham BH,Chen W,Gripp KW,Jenny K,Wienker TF,Yang Y,Sutton VR,Gibbs RA,Ropers HH

    更新日期:2013-02-05 00:00:00

  • Polygenic risk scores: from research tools to clinical instruments.

    abstract::Genome-wide association studies have shown unequivocally that common complex disorders have a polygenic genetic architecture and have enabled researchers to identify genetic variants associated with diseases. These variants can be combined into a polygenic risk score that captures part of an individual's susceptibilit...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-020-00742-5

    authors: Lewis CM,Vassos E

    更新日期:2020-05-18 00:00:00

  • Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.

    abstract:BACKGROUND:Alzheimer's disease affects ~13% of people in the United States 65 years and older, making it the most common neurodegenerative disorder. Recent work has identified roles for environmental, genetic, and epigenetic factors in Alzheimer's disease risk. METHODS:We performed a genome-wide screen of DNA methylat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0258-8

    authors: Watson CT,Roussos P,Garg P,Ho DJ,Azam N,Katsel PL,Haroutunian V,Sharp AJ

    更新日期:2016-01-19 00:00:00

  • Overcoming bias and systematic errors in next generation sequencing data.

    abstract::Considerable time and effort has been spent in developing analysis and quality assessment methods to allow the use of microarrays in a clinical setting. As is the case for microarrays and other high-throughput technologies, data from new high-throughput sequencing technologies are subject to technological and biologic...

    journal_title:Genome medicine

    pub_type: 社论

    doi:10.1186/gm208

    authors: Taub MA,Corrada Bravo H,Irizarry RA

    更新日期:2010-12-10 00:00:00

  • Best practices for bioinformatic characterization of neoantigens for clinical utility.

    abstract::Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens and to create personalized immunotherapies for cancer treatment. To cr...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-019-0666-2

    authors: Richters MM,Xia H,Campbell KM,Gillanders WE,Griffith OL,Griffith M

    更新日期:2019-08-28 00:00:00

  • The Human Gene Mutation Database: 2008 update.

    abstract::The Human Gene Mutation Database (HGMD((R))) is a comprehensive core collection of germline mutations in nuclear genes that underlie or are associated with human inherited disease. Here, we summarize the history of the database and its current resources. By December 2008, the database contained over 85,000 different l...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm13

    authors: Stenson PD,Mort M,Ball EV,Howells K,Phillips AD,Thomas NS,Cooper DN

    更新日期:2009-01-22 00:00:00

  • DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial.

    abstract:BACKGROUND:One of the major challenges in obesity treatment is to explain the high variability in the individual's response to specific dietary and physical activity interventions. With this study, we tested the hypothesis that specific DNA methylation changes reflect individual responsiveness to lifestyle intervention...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00794-7

    authors: Keller M,Yaskolka Meir A,Bernhart SH,Gepner Y,Shelef I,Schwarzfuchs D,Tsaban G,Zelicha H,Hopp L,Müller L,Rohde K,Böttcher Y,Stadler PF,Stumvoll M,Blüher M,Kovacs P,Shai I

    更新日期:2020-11-16 00:00:00

  • A phylogeny-based sampling strategy and power calculator informs genome-wide associations study design for microbial pathogens.

    abstract::Whole genome sequencing is increasingly used to study phenotypic variation among infectious pathogens and to evaluate their relative transmissibility, virulence, and immunogenicity. To date, relatively little has been published on how and how many pathogen strains should be selected for studies associating phenotype a...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-014-0101-7

    authors: Farhat MR,Shapiro BJ,Sheppard SK,Colijn C,Murray M

    更新日期:2014-11-15 00:00:00